Traditional Chinese medicine composition for treating bronchiectasia

Abstract

The invention discloses a traditional Chinese medicine composition for treating bronchiectasia. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 3-6 parts of eclipta, 2-4 parts of prepared polygonum multiflorum, 3-5 parts of liquorice, 5-7 parts of semen coicis, 2-4 parts of platycodon grandiflorum, 7-9 parts of lalang grass rhizome, 1-3 parts of coptis chinensis, 3-5 parts of madder, 5-7 parts of radix rehmanniae, 3-5 parts of lalang grass rhizome, 2-4 parts of setose thistle, 7-9 parts of scutellaria baicalensis, 4-6 parts of flos farfarae, 2-4 parts of dandelion, 4-6 parts of cordate houttuynia, 8-10 parts of loofah sponge, 2-4 parts of wupifeng (Chinese character), 1-3 parts of madake bamboo root, 3-5 parts of food of goddess, 2-4 parts of manystem stonecrop leaf, 5-7 parts of herba orostachyos, 5-8 parts of groundnut leaf, 2-4 parts of caudate desmodium and 1-3 parts of veronica nagalis-aquatica. The traditional Chinese medicine composition disclosed by the invention has the effects of relieving exterior syndrome and clearing heat, discharging fire and reducing phlegm, appropriating lung and relieving a cough, and the like, and is good in curative effect on the bronchiectasia, quick to take effect, and free of toxic and side effects; the healing rate can be up to 98%.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for treating bronchiectasis, which belongs to the field of traditional Chinese medicines. Background technique [0002] Bronchiectasis is due to chronic suppurative inflammation and fibrosis of the bronchi and its surrounding lung tissue, which destroys the muscle and elastic tissue of the bronchial wall, resulting in deformation and persistent dilation of the bronchi; typical symptoms include chronic cough, coughing up a large amount of purulent sputum, and repeated hemoptysis; At present, clinical treatment is based on anti-inflammatory, phlegm-reducing, anti-asthma, or surgical resection, but the curative effect is not ideal. Some patients rely on drugs for a long time and develop drug resistance, with many side effects, decreased immune function of patients, and dysfunction of viscera. Contents of the invention [0003] The object of the present invention is to provide a traditio...

AI Technical Summary

Problems solved by technology

[0002] Bronchiectasis is due to chronic suppurative inflammation and fibrosis of the bronchi and its surrounding lung tissue, which destroys the muscle and elastic tissue of the bronchial wall, resulting in deformation and persistent dilation of the bronchi; typical symptoms include chronic cough, coughing up a large amount of purulent sputum, and repeated hemoptysis; At present, the clinical treatment is mainly anti-inflammatory, phlegm-reducing, and asthma-relieving, or surgical resection, but the curative effect is not satisfactory. Some patients rely on drugs for a long time and develop drug resistance, with many side effects, which make the patient’s immune function decline and viscera dysfunction.